Advertisement
Screener

Eledon Pharmaceuticals, Inc. (ELDN) Accrued Vacation, Current

2.8 / 5 stars · 68/120 Roast Me

Eledon Pharmaceuticals, Inc. Accrued Vacation, Current

Eledon Pharmaceuticals, Inc. (ELDN) had Accrued Vacation, Current of $148.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-12.

Discontinued › Notes

us-gaap:AccruedVacationCurrent · last filed 2021-11-12

  • 2021-09-30: Accrued Vacation, Current $148.00K.
  • 2021-06-30: Accrued Vacation, Current $176.00K.
  • 2021-03-31: Accrued Vacation, Current $128.00K.
  • 2020-12-31: Accrued Vacation, Current $67.00K.
Period endAccrued Vacation, Current
2021-09-30$148.00K
10-Q · filed 2021-11-12
2021-06-30$176.00K
10-Q · filed 2021-08-12
2021-03-31$128.00K
10-Q · filed 2021-05-14
2020-12-31$67.00K
10-Q · filed 2021-11-12
2020-09-30$55.00K
10-Q · filed 2020-11-16
2020-06-30$115.00K
10-Q · filed 2020-08-14
2020-03-31$212.00K
10-Q · filed 2020-05-15
2019-12-31$199.00K
10-K · filed 2021-03-31
2019-09-30$188.00K
10-Q · filed 2019-11-13
2019-06-30$200.00K
10-Q · filed 2019-08-13
2019-03-31$188.00K
10-Q · filed 2019-05-14
2018-12-31$160.00K
10-K · filed 2020-03-17
2018-09-30$131.00K
10-Q · filed 2018-11-13
2018-06-30$135.00K
10-Q · filed 2018-08-07
2018-03-31$138.00K
10-Q · filed 2018-05-11
2017-12-31$111.00K
10-K · filed 2019-03-28
2017-09-30$102.00K
10-Q · filed 2017-11-08
2017-06-30$122.00K
10-Q · filed 2017-08-09
2016-12-31$50.00K
10-K · filed 2018-04-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Foghorn Therapeutics Inc. (FHTX)United States$0.213B-4.43
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Nkarta, Inc. (NKTX)United States$0.205B-1.73
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12